IRIS
SPORTIELLO, Liberata
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.956
AS - Asia 1.895
NA - Nord America 1.696
SA - Sud America 348
AF - Africa 33
OC - Oceania 3
AN - Antartide 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.933
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.665
RU - Federazione Russa 1.451
SG - Singapore 641
CN - Cina 495
IE - Irlanda 465
IT - Italia 359
BR - Brasile 288
HK - Hong Kong 237
VN - Vietnam 170
GB - Regno Unito 169
DE - Germania 149
UA - Ucraina 129
KR - Corea 98
JP - Giappone 83
IN - India 56
GR - Grecia 47
FI - Finlandia 46
TR - Turchia 37
AR - Argentina 29
FR - Francia 26
SE - Svezia 26
ID - Indonesia 18
CA - Canada 17
ZA - Sudafrica 16
EC - Ecuador 15
AT - Austria 14
NL - Olanda 14
BE - Belgio 13
BD - Bangladesh 10
IQ - Iraq 10
ES - Italia 9
CZ - Repubblica Ceca 8
IR - Iran 8
MA - Marocco 7
IL - Israele 6
MX - Messico 6
PL - Polonia 6
CL - Cile 5
DK - Danimarca 5
PY - Paraguay 5
CH - Svizzera 4
EG - Egitto 3
JM - Giamaica 3
KE - Kenya 3
NP - Nepal 3
PE - Perù 3
PK - Pakistan 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AM - Armenia 2
BG - Bulgaria 2
BY - Bielorussia 2
CO - Colombia 2
DZ - Algeria 2
HR - Croazia 2
JO - Giordania 2
KG - Kirghizistan 2
LV - Lettonia 2
RS - Serbia 2
TN - Tunisia 2
AQ - Antartide 1
AU - Australia 1
DO - Repubblica Dominicana 1
EU - Europa 1
GE - Georgia 1
GT - Guatemala 1
KH - Cambogia 1
KI - Kiribati 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MN - Mongolia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
VE - Venezuela 1
Totale 6.933
Salva come PNG Salva come JPEG
Città #
Moscow 483
Dublin 462
Singapore 296
Santa Clara 271
Hong Kong 236
Jacksonville 206
Chandler 176
Seoul 96
Beijing 82
Ashburn 81
Hefei 78
Ann Arbor 68
Dong Ket 66
Princeton 54
Aversa 50
Roxbury 48
Medford 46
Bremen 45
Ho Chi Minh City 39
Woodbridge 34
Bengaluru 33
The Dalles 32
Caserta 28
Wilmington 28
Naples 27
Düsseldorf 26
Dallas 22
São Paulo 22
Hanoi 21
Mountain View 21
Nanjing 21
New York 19
Des Moines 17
Genoa 17
Los Angeles 16
Munich 16
Boardman 15
Dearborn 15
Brussels 13
Milan 13
Cambridge 12
Kunming 12
Jinan 11
Nuremberg 11
Falkenstein 10
Helsinki 10
Johannesburg 10
Napoli 10
Rome 10
Jakarta 9
Auburn Hills 8
Hanover 8
London 8
Messina 8
Pomigliano d'Arco 8
Salerno 8
Amsterdam 7
Brasília 7
Brno 7
Curitiba 7
Guangzhou 7
San Mateo 7
Shenyang 7
Stockholm 7
Vienna 7
Biên Hòa 6
Changsha 6
Chengdu 6
Guarulhos 6
Norwalk 6
San Francisco 6
Toronto 6
Asunción 5
Atlanta 5
Belo Horizonte 5
Cagliari 5
Columbus 5
Da Nang 5
Hebei 5
Manchester 5
Nanchang 5
Redwood City 5
Rio de Janeiro 5
Tel Aviv 5
Venice 5
Avellino 4
Boston 4
Can Tho 4
Cape Town 4
Chennai 4
Giugliano in Campania 4
Guayaquil 4
Houston 4
Juelsminde 4
Mexico City 4
Padova 4
Paris 4
Quito 4
Tianjin 4
Washington 4
Totale 3.722
Salva come PNG Salva come JPEG
Nome #
Adverse drug reactions and gender differences: What changes in drug safety? 161
Predictors of mortality in atypical antipsychotic-treated community-dwelling elderly patients with behavioural and psychological symptoms of dementia: a prospective population-based cohort study from Italy 146
Bisphosphonate-related osteonecrosis of the jaw: an italian post-marketing surveillance analysis 146
Safety profile of anticancer and immune-modulating biotech drugs used in a real world setting in Campania Region (Italy): BIO-Cam observational study 144
Campania preventability assessment committee (Italy): A focus on the preventability of non-steroidal anti-inflammatory drugs' adverse drug reactions 131
Contrast media-induced nephropathy: how has Italy contributed in the past 30 years? A systematic review 130
Campania Region (Italy) spontaneous reporting system and preventability assessment through a case-by-case approach: a pilot study on psychotropic drugs 128
Trends in the prescription of antidiabetic medications from 2009 to 2012 in a general practice of Southern Italy: A population-based study. 126
Therapeutic drug monitoring of second-generation antipsychotics in pediatric patients: An observational study in real-life settings 122
Complete resistance after maximal dose of rocuronium 120
Medication adherence and the use of new pharmaceutical formulations: The case of levothyroxine 119
Improvement of patient adverse drug reaction reporting through a community pharmacist-based intervention in the Campania region of Italy 115
Pattern of statin use in southern Italian primary care: Can prescription databases be used for monitoring long-term adherence to the treatment? 114
Campania preventability assessment committee: a focus on the preventability of the contrast media adverse drug reactions 113
Anti-inflammatory role of SGLT2 inhibitors as part of their anti-atherosclerotic activity: Data from basic science and clinical trials 112
Analysis of fatal adverse drug events recorded in several Italian emergency departments (the MEREAFaPS study) 111
Risk of gastrointestinal complications associated to NSAIDs, low-dose aspirin and their combinations: Results of a pharmacovigilance reporting system 107
Biosimilars in the European Union from comparability exercise to real world experience: What we achieved and what we still need to achieve 107
Adverse drug reactions during hepatitis C treatment with direct-acting antivirals: The role of medication errors, their impact on treatment discontinuation and their preventability. New insights from the Campania Region (Italy) spontaneous reporting system 107
Comparison of long-term clinical implications of beta-blockade in patients with obstructive airway diseases exposed to beta-blockers with different β1-adrenoreceptor selectivity: An Italian population-based cohort study 104
Dipeptidyl Peptidase (DPP)-4 Inhibitor-Induced Arthritis/Arthralgia: A Review of Clinical Cases 104
The importance of Pharmacovigilance for the drug safety: Focus on cardiovascular profile of incretin-based therapy 99
Disclosing negative trial results – procedure 97
Capillary leak syndrome following COVID-19 vaccination: Data from the European pharmacovigilance database Eudravigilance 96
Current pharmacological treatments for COVID-19: What's next? 96
Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary 95
Safety of attention-deficit/hyperactivity disorder medications in children: an intensive pharmacosurveillance monitoring study. 95
Beta-blocker choice and exchangeability in patients with heart failure and chronic obstructive pulmonary disease: an Italian register-based cohort study 95
Can causality assessment fulfill the new European definition of adverse drug reaction? A review of methods used in spontaneous reporting( 94
Persistence in therapy with risperidone and aripiprazole in pediatric outpatients: A 2-year naturalistic comparison 93
Did the new Italian law on mandatory vaccines affect adverse event Following immunization's reporting? A pharmacovigilance study in Southern Italy 93
Second generation antipsychotics in ‘real-life’ paediatric patients. Adverse drug reactions and clinical outcomes of drug switch 91
Hospital consumption of antibiotics at the Policlinico Hospital of the Second University of Naples: results of retrospective data collection 89
Italian Emergency Department Visits and Hospitalizations for Outpatients’ Adverse Drug Events: 12-Year Active Pharmacovigilance Surveillance (The MEREAFaPS Study) 88
Do immune checkpoint inhibitors share the same pharmacological feature in the risk of cardiac arrhythmias? 87
Efficacy and safety of insulin-GLP-1 receptor agonists combination in type 2 diabetes mellitus: a systematic review 87
Neurological Manifestations Related to Immune Checkpoint Inhibitors: Reverse Translational Research by Using the European Real-World Safety Data 86
Overview of Antiviral Drug Therapy for COVID-19: Where Do We Stand? 85
Did the COVID-19 Pandemic Affect Contrast Media-Induced Adverse Drug Reaction’s Reporting? A Pharmacovigilance Study in Southern Italy 85
Immune-related adverse events and immune checkpoint inhibitors: a focus on neurotoxicity and clinical management 84
Contribution of Italian clinical research for contrast media-induced nonrenal adverse drug reactions over the last three decades: A systematic review 84
DPP-4 inhibitors: Pharmacological differences and their clinical implications 83
Dipeptidyl peptidase-4 inhibitors in type 2 diabetes therapy--focus on alogliptin. 83
New era in treatment options of chronic hepatitis C: focus on safety of new direct-acting antivirals (DAAs) 81
Maternal, fetal and neonatal outcomes among pregnant women receiving COVID-19 vaccination: The preg-co-vax study 80
Rational use of antibiotics for the management of children's respiratory tract infections in the ambulatory setting: An evidence-based consensus by the Italian Society of Preventive and Social Pediatrics 80
Disease-Modifying Therapies (DMTs) in Pregnant and Lactating Women with Multiple Sclerosis: Analysis of Real-World Data from EudraVigilance Database 79
Pregnancy Recommendations Solely Based on Preclinical Evidence Should Be Integrated with Real-World Evidence: A Disproportionality Analysis of Certolizumab and Other TNF-Alpha Inhibitors Used in Pregnant Patients with Psoriasis 77
Notification of undesirable effects of cosmetics and toiletries 76
Thromboembolic Events after COVID-19 Vaccination: An Italian Retrospective Real-World Safety Study 76
PCSK9 Inhibitors and Neurocognitive Adverse Drug Reactions: Analysis of Individual Case Safety Reports from the Eudravigilance Database 75
Should we abandon statins in the prevention of bone fractures? 74
Immune Checkpoint Inhibitors and Immune-Related Adverse Drug Reactions: Data From Italian Pharmacovigilance Database 74
Glucagon-like Peptide-1 Receptor Agonists and Suicidal Ideation: Analysis of Real-Word Data Collected in the European Pharmacovigilance Database 73
Mineralocorticoid receptor antagonists in heart failure with preserved ejection fraction (HFpEF) 73
Therapeutic strategies to fight COVID-19: Which is the status artis? 72
Risk of acute and serious liver injury associated to nimesulide and other NSAIDs: data from drug-induced liver injury case–control study in Italy 71
Pillars and Pitfalls of the New Pharmacovigilance legislation: Consequences for the identification of adverse drug reactions deriving from abuse, misuse, overdose, occupational exposure, and medication errors 71
Preventable statin adverse reactions and therapy discontinuation. What can we learn from the spontaneous reporting system? 70
SGLT2 breast expression could affect the cardiovascular performance in pre-menopausal women with fatty vs. non fatty breast via over-inflammation and sirtuins' down regulation 68
Drugs approved for the treatment of multiple sclerosis: review of their safety profile 68
No substantial gender differences in suspected adverse reactions to ACE inhibitors and ARBs: results from spontaneous reporting system in Campania Region 67
Drugs-induced pathological gambling: An analysis of italian spontaneous reporting system 67
Surveillance of adverse events following immunization related to human papillomavirus vaccines: 12 years of vaccinovigilance in Southern Italy 67
Neutral endopeptidase (neprilysin) 65
Which is the top player for the cardiovascular safety? ibrutinib vs. obinutuzumab in CLL 64
Preventable cases of oral anticoagulant-induced bleeding: Data from the spontaneous reporting system 64
Risk of hospitalisation associated with benzodiazepines and z-drugs in Italy: a nationwide multicentre study in emergency departments 64
Disproportionality analysis of European safety reports on autoimmune and rheumatic diseases following COVID-19 vaccination 63
Quinolones-Induced Musculoskeletal, Neurological, and Psychiatric ADRs: A Pharmacovigilance Study Based on Data From the Italian Spontaneous Reporting System 62
Oropharyngeal Adverse Events to Drugs and Vaccines: Pharmacovigilance Data From Italy (2019-2021) 61
Lymphopenia associated with sphingosine 1-phosphate receptor modulators (S1PRMs) in multiple sclerosis: analysis of European pharmacovigilance data 61
Suspected adverse reactions to contrast media in Campania Region (Italy): Results from 14 years of post-marketing surveillance 58
Disease-modifying therapies and hematological disorders: a systematic review of case reports and case series 56
The Pharmacological Treatment of Chronic Pain: From Guidelines to Daily Clinical Practice 53
MicroRNA Monitoring in Human Alveolar Macrophages from Patients with Smoking-Related Lung Diseases: A Preliminary Study 53
The amount of DNA combined with TP53 mutations in liquid biopsy is associated with clinical outcome of renal cancer patients treated with immunotherapy and VEGFR-TKIs 51
It is the time to change the paradigms of pregnant and breastfeeding women in clinical research! 49
Overview of the European post-authorisation study register post-authorization studies performed in Europe from September 2010 to December 2018 43
Sex and gender differences and pharmacovigilance: a knot still to be untied 42
Oropharyngeal adverse drug reactions: knowledge, attitudes, and practice (KAP) among Italian healthcare professionals and students 33
Immune checkpoint inhibitors and metabolic events: results from a European safety analysis. 29
Hypogammaglobulinemia and infections in patients with multiple sclerosis treated with anti-CD20 monoclonal antibodies: a systematic review and meta-analysis of observational studies. 22
Totale 7.084
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.240
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.240
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021246 0 0 0 0 0 6 45 36 9 22 57 71
2021/2022338 9 8 2 3 123 10 12 9 15 16 22 109
2022/2023872 91 21 12 58 95 58 6 48 423 6 35 19
2023/2024424 26 10 30 23 122 27 12 48 21 16 29 60
2024/20251.307 10 31 28 41 180 193 194 117 195 100 114 104
2025/20262.894 254 320 311 299 510 1.200 0 0 0 0 0 0
Totale 7.084